New Trends in Cyclodextrins Technology for Pharmaceutical
A new book is expected to be published on Nov. 1, 2026 by Elsevier with subtitle: Innovations Based on Cyclodextrins
A forum for researchers, students and applicants in the field of cyclodextrin technology
A new book is expected to be published on Nov. 1, 2026 by Elsevier with subtitle: Innovations Based on Cyclodextrins
Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are neurodegenerative disorders characterised by cognitive dysfunction and neurological impairment. In
This study fabricated a β/γ-CD-MOF composite via β-CD and γ-CD hybridization, incorporating the hydrophobic anti-inflammatory agent atorvastatin, followed by surface
The potential cardiometabolic and glucometabolic benefits of cyclodextrins have been widely published; however, evidence from randomized controlled trials (RCTs) remains
Because of their strong complexation behavior, guest-host interactions between adamantane (Ad) and β-cyclodextrin (CD) are often used to create physically
In this study, we present the first systematic investigation of host–guest interactions in poly-CD NF using spin-labeled electron spin resonance
Realizing reliable medicine anticounterfeiting with safe and robust materials remains a challenge. A class of edible phosphorescent supramolecules (VB10@α/β-CDs) based
The aim of this Thematic Issue in Beilstein Journal of Organic Chemistry is to spotlight the most groundbreaking research on
Fungal keratitis (FK) is a leading cause of corneal blindness worldwide. Although voriconazole (VOR) is effective, its poor corneal permeability
3D cyclodextrin-based metal-organic frameworks (CD-MOFs) have emerged as a biocompatible alternative to conventional MOFs, as they are synthesized using safer,